Literature DB >> 28283819

Neurological complications of Behçet's syndrome.

D P Kidd1.   

Abstract

In this review of the neurological complications of Behçet's syndrome, the clinical features and epidemiology of the systemic disease are summarised before a discussion of the neurological syndromes which may develop is made. Neurological involvement occurs in 9% of cases, and is equally prevalent in each geographical area. Vascular complications occur in 14%, in whom thrombosis of the venous sinuses or cerebral veins occurs, and intracranial hypertension, venous infarction and parenchymal haemorrhage may develop. There is a correlation with the prevalence of peripheral venous thrombosis. Concurrent inflammatory disease of the brain is most uncommon. Inflammation may affect any part of the central nervous system, but most commonly involves a subacute meningoencephalitis of the brainstem and diencephalon. Inflammatory lesions elsewhere in the brain and in the spinal cord may occur, and tumefactive lesions may arise from the diencephalon. Cognitive dysfunction and affective symptoms, including psychosis, may occur, and there are high levels of anxiety and fatigue which are related to the severity of the systemic disease, all of which are more severe in those with neurological involvement. Imaging shows enhancing lesions which often disappear after treatment, but atrophy is common. The CSF is active when there is a meningoencephalitis, and oligoclonal bands do not occur. Treatment is with steroids and immunosuppression. Those with treatment resistant disease respond to biological agents, including TNF alpha, IL-1 and IL-6 antagonists.

Entities:  

Keywords:  Behçet’s syndrome; Neuro-Behçet’s; Neurological complications

Mesh:

Year:  2017        PMID: 28283819     DOI: 10.1007/s00415-017-8436-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

1.  Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.

Authors:  A Al-Araji; K Sharquie; Z Al-Rawi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

Review 2.  Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.

Authors:  Nicolò Pipitone; Ignazio Olivieri; Angela Padula; Salvatore D'angelo; Angelo Nigro; Giulio Zuccoli; Luigi Boiardi; Carlo Salvarani
Journal:  Arthritis Rheum       Date:  2008-02-15

3.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

Review 4.  New therapeutic solutions for Behçet's syndrome.

Authors:  Antonio Vitale; Donato Rigante; Giuseppe Lopalco; Giacomo Emmi; Maria Teresa Bianco; Mauro Galeazzi; Florenzo Iannone; Luca Cantarini
Journal:  Expert Opin Investig Drugs       Date:  2016-05-10       Impact factor: 6.206

5.  Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.

Authors:  S Hirohata; K Isshi; H Oguchi; T Ohse; H Haraoka; A Takeuchi; T Hashimoto
Journal:  Clin Immunol Immunopathol       Date:  1997-01

6.  The natural course and factors affecting severity of Behçet's disease: a single-center cohort of 368 patients.

Authors:  Nilay Ugurlu; Selen Bozkurt; Ali Bacanli; Ayse Akman-Karakas; Soner Uzun; Erkan Alpsoy
Journal:  Rheumatol Int       Date:  2015-06-18       Impact factor: 2.631

7.  Neurological manifestations of Behçet's disease in Japan: a study of 54 patients.

Authors:  Haruko Ideguchi; Akiko Suda; Mitsuhiro Takeno; Yohei Kirino; Atsushi Ihata; Atsuhisa Ueda; Shigeru Ohno; Yasuhisa Baba; Yoshiyuki Kuroiwa; Yoshiaki Ishigatsubo
Journal:  J Neurol       Date:  2010-02-03       Impact factor: 4.849

8.  Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases.

Authors:  B Wechsler; M Vidailhet; J C Piette; M G Bousser; B Dell Isola; O Blétry; P Godeau
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

9.  Treatment of retinal vasculitis in Behçet's disease with rituximab.

Authors:  Shahram Sadreddini; Hamid Noshad; Mahshid Molaeefard; Rahim Noshad
Journal:  Mod Rheumatol       Date:  2008-04-26       Impact factor: 3.023

10.  Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.

Authors:  D P Kidd
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

View more
  5 in total

1.  In vivo confocal microscopy for eyes with Behçet's disease: a missing piece of the puzzle.

Authors:  Yi-Hsun Huang; Jia-Horung Hung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-29       Impact factor: 3.535

2.  Trends in Hospitalization and Inpatient Outcomes of Behçet's Disease: A Nationwide Inpatient Sample Study.

Authors:  Srikanth Naramala; Venu Madhav Konala; Sreedhar Adapa; Vijay Gayam; Jasdeep Sidhu; Sharmi Biswas; Mamtha Balla; Ganesh Prasad Merugu; Debendra Pattanaik
Journal:  Cureus       Date:  2020-03-30

3.  Case Report: Repeated Low-Dose Rituximab Treatment Is Effective in Relapsing Neuro Behçet's Disease.

Authors:  Chao Zhao; Chuan Li; Feng-Ju Duan; Qi Yan; Zhuo Zhang; Ying Du; Wei Zhang
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

4.  Association of Behçet disease with psoriasis and psoriatic arthritis.

Authors:  Hyung Jin Hahn; Sang Gyu Kwak; Dong-Kyu Kim; Jong-Yeup Kim
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

Review 5.  Central and Peripheral Nervous System Complications of Vasculitis Syndromes From Pathology to Bedside: Part 1-Central Nervous System.

Authors:  Gelsomina Mansueto; Giuseppe Lanza; Francesco Fisicaro; Danielle Alaouieh; Emily Hong; Sara Girolami; Marco Montella; Alessandro Feola; Mario Di Napoli
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-09       Impact factor: 6.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.